Picard Medical (PMI) Income towards Parent Company (2024 - 2026)

Picard Medical (PMI) has reported Income towards Parent Company for 3 consecutive years, with -$5.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Income towards Parent Company rose 15.82% year-over-year to -$5.7 million; the trailing twelve-month figure through Jun 2026 stood at -$22.3 million (up 2.59% YoY), and the FY2025 full-year result was -$21.3 million, down 28.17% from the prior year.
• Income towards Parent Company grew to -$5.7 million in Q2 2026 per PMI's latest filing, from -$7.6 million in the prior quarter.
• Across five years, Income towards Parent Company topped out at $1.4 million in Q4 2025 and bottomed at -$10.4 million in Q3 2025.
• Historically, Income towards Parent Company has averaged -$5.5 million across 3 years, with a median of -$5.7 million in 2026.
• The widest YoY moves for Income towards Parent Company: up 130.96% in 2025, down 68.0% in 2025.
• Over 3 years, Income towards Parent Company stood at -$4.4 million in 2024, then surged by 130.96% to $1.4 million in 2025, then tumbled by 512.54% to -$5.7 million in 2026.
• According to Business Quant data, Income towards Parent Company over the past three periods registered -$5.7 million, -$7.6 million, and $1.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.